ICD-10-CM Billable Code

Z16.1

Resistance to beta lactam antibiotics

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code Z16.1 refers to resistance to beta-lactam antibiotics, a significant concern in the treatment of bacterial infections. This condition indicates that bacteria have developed the ability to withstand the effects of beta-lactam antibiotics, making infections harder to treat. Beta-lactam antibiotics, including penicillins and cephalosporins, are widely used to combat various bacterial illnesses. However, the emergence of resistance reduces their effectiveness and poses challenges for healthcare providers. Recognizing and understanding antibiotic resistance is essential for proper infection management and public health.

Causes & Symptoms

Clinical Causes: Overuse or misuse of antibiotics, leading to selective pressure that encourages resistant bacteria to thrive. Incomplete courses of antibiotic therapy, allowing some bacteria to survive and adapt resistance mechanisms. Horizontal gene transfer among bacteria, which facilitates the spread of resistance genes. Use of antibiotics in agriculture and livestock, contributing to environmental reservoirs of resistance. Presence of high bacterial loads in infections, increasing the chances of resistance development.

Key Symptoms: Persistent or worsening infection symptoms despite antibiotic treatment. Recurrent infections, indicating previous unsuccessful therapies. Infections that are difficult to eradicate or require alternative or combination therapies. Signs of systemic infection such as fever, chills, or fatigue, which do not improve with standard antibiotics.

Diagnostic & Treatment

Diagnosis Path: Diagnosis of antibiotic resistance involves laboratory testing, including susceptibility testing on bacterial samples obtained from infections. Culturing bacteria and exposing them to various antibiotics helps determine their susceptibility profile. Confirming resistance to beta-lactam antibiotics guides healthcare professionals in selecting effective alternative treatments and management strategies.

Treatment Protocols: Utilizing combination therapies to overcome resistance mechanisms. Implementing antimicrobial stewardship programs to promote appropriate antibiotic use. Monitoring and controlling infection spread within healthcare settings. Researching and developing new antibiotics with mechanisms that circumvent existing resistance. Supporting infection prevention measures, such as good hygiene and vaccination, to reduce infection rates.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is Z16.1 a billable ICD-10 code?
Yes, Z16.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report Z16.1?
Clinical documentation must specify the nature of Resistance to beta lactam antibiotics and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

lactam antibiotics resistance